Discovery of AMG 925, a FLT3 and CDK4 dual kinase inhibitor with preferential affinity for the activated state of FLT3.
Li, Z., Wang, X., Eksterowicz, J., Gribble, M.W., Alba, G.Q., Ayres, M., Carlson, T.J., Chen, A., Chen, X., Cho, R., Connors, R.V., DeGraffenreid, M., Deignan, J.T., Duquette, J., Fan, P., Fisher, B., Fu, J., Huard, J.N., Kaizerman, J., Keegan, K.S., Li, C., Li, K., Li, Y., Liang, L., Liu, W., Lively, S.E., Lo, M.C., Ma, J., McMinn, D.L., Mihalic, J.T., Modi, K., Ngo, R., Pattabiraman, K., Piper, D.E., Queva, C., Ragains, M.L., Suchomel, J., Thibault, S., Walker, N., Wang, X., Wang, Z., Wanska, M., Wehn, P.M., Weidner, M.F., Zhang, A.J., Zhao, X., Kamb, A., Wickramasinghe, D., Dai, K., McGee, L.R., Medina, J.C.
J.Med.Chem.
